Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.15% | 146.47% | 236.92% | 514.08% | 1,397.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.15% | 146.47% | 236.92% | 514.08% | 1,397.05% |
| Cost of Revenue | -24.90% | -29.50% | -37.91% | -22.03% | -11.61% |
| Gross Profit | 47.34% | 59.15% | 60.75% | 45.12% | 29.02% |
| SG&A Expenses | -21.64% | -23.26% | -23.60% | -8.64% | -5.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.30% | -26.47% | -31.22% | -15.76% | -8.51% |
| Operating Income | 33.22% | 40.32% | 42.64% | 27.65% | 17.59% |
| Income Before Tax | 54.29% | 57.45% | -3.99% | -17.48% | -24.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 54.29% | 57.45% | -3.99% | -17.48% | -24.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.29% | 57.45% | -3.99% | -17.48% | -24.87% |
| EBIT | 33.22% | 40.32% | 42.64% | 27.65% | 17.59% |
| EBITDA | 34.30% | 41.69% | 44.08% | 28.62% | 18.19% |
| EPS Basic | 54.71% | 57.85% | -0.57% | -10.65% | -14.76% |
| Normalized Basic EPS | 34.28% | 42.88% | 47.55% | 34.72% | 27.53% |
| EPS Diluted | 54.71% | 57.85% | -0.57% | -10.65% | -14.76% |
| Normalized Diluted EPS | 34.28% | 42.88% | 47.55% | 34.72% | 27.53% |
| Average Basic Shares Outstanding | 0.99% | 1.14% | 3.35% | 5.80% | 8.51% |
| Average Diluted Shares Outstanding | 0.99% | 1.14% | 3.35% | 5.80% | 8.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |